KaloBios Pharmaceuticals, Inc. (KBIO) is “One to Watch”
With more people across the U.S. faced with the unpleasant fact that healthcare and pharmaceutical costs are exceptionally high and continuing to grow, KaloBios Pharmaceuticals, Inc. (OTC: KBIO) is taking a step closer to positive change with new, innovative, and responsible pricing models. The company is leading a new way of thinking regarding how medicines are priced, and how to tackle neglected and rare diseases. KBIO is advancing treatments and medicines for patients through innovative and responsible business models, leading by example with concrete operational changes, such as its Responsible Pricing Model. This model was recently recognized in an article…







